Dr. Violeta Rus, MD

Dr. Rus practices at University of Maryland Rehabilitation & Orthopaedic Institute in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Rus' NPI, 1285681320, was assigned on May 27, 2006. Dr. Rus holds Maryland license D51494.

Dr. Rus' primary practice is University of Maryland Rehabilitation & Orthopaedic Institute, at 2200 Kernan Drive, Baltimore, MD 21207 in Baltimore County. The practice phone is (410) 448-6701.

Dr. Rus' primary practice is University of Maryland Rehabilitation & Orthopaedic Institute in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Rus is also affiliated with University of Maryland Medical Center. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rus practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Rus' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Rus is licensed in Maryland.

CMS data shows 123 Medicare services from Dr. Rus across 2 procedure codes in 2024, for 70 Medicare patients. Medicare paid $7,321 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Rus in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 74% have arthritis. 41% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rus' median patient age at 59, with 85% women.

In 2024, Dr. Rus wrote 639 Medicare Part D claims for 72 patients. 86% of them were for generic drugs. CMS names the drug for 481 of them, across 15 drugs with 11 or more claims each, at $315,766 in total drug cost. In 2023, CMS named 527 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rus for performance year 2024, reported as part of a group. Dr. Rus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rus as offering telehealth.

Dmand AI links 40 papers to Dr. Rus, published from 2011 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Nerve Tissue Proteins, Cell Cycle Proteins and Muscle Proteins. Dr. Rus has published most often in Exp Mol Pathol. Dr. Rus' most frequent co-authors are Cornelia Diana Cudrici, MD, Cosmin Tegla, MD and Armugam Prasad Mekala, MD.

Dmand AI links Dr. Rus to 1 clinical trial. Conditions studied include Lupus Erythematosus, Systemic and Connective Tissue Diseases.

CMS Open Payments shows 24 general payments to Dr. Rus from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 94% of the total. Horizon Pharma plc paid the most, $16,250. It also lists 2 research payments totaling $1,341 in 2025.